Coronavirus (COVID-19)

This page contains medical information for clinicians on the 2019 Novel Coronavirus (COVID-19, also called 2019-nCoV, and now clinically SARS‐CoV‐2). This section includes articles that pertain to clinicians and cardiologists on the virus, new technologies being deployed to fight the virus and clinical information from various sources. Here are direct links for medical professionals to COVID-19 resources from the U.S. Food and Drug Administration (FDA), Centers for Disease Control (CDC) and the World Health Organization (WHO). Daily world-wide statistics on the coronavirus outbreak are available from the WHO Situations Reports. Here is the Centers for Medicare and Medicaid Services (CMS) frequently asked questions and answers (FAQs) for healthcare providers regarding Medicare payment for laboratory tests and other services related to the COVID-19.

A recent Society for Cardiovascular Angiography and Interventions (SCAI) survey found nearly 40 percent of Americans still do not feel safe going to the doctor's office while coronavirus is still a risk. Survey respondents also said they are more afraid of catching the virus than they are of a heart attack or stroke, which may delay critical treatment. Getty Images
News | Coronavirus (COVID-19)
SCAI Study Shows COVID Fears Continue to Cause Americans to Avoid Doctor Visits

January 18, 2021 — According to a new national survey released Jan. 13 by the Society for Cardiovascular Angiography and ...

Home January 18, 2021
Home
Myocarditis among recovering COVID-19 athletes less common than previously reported
News | Coronavirus (COVID-19)
Cardiac MRI Shows Lower Degrees of Myocarditis in Athletes Recovered from COVID-19

January 11, 2021 — In a letter published in the December issue of the American Heart Association (AHA) medical journal C ...

Home January 12, 2021
Home
The AHA and American Medical Society for Sports Medicine are collaborating to evaluate impact of COVID on the hearts of athletes, improve detection and inform safe return to play. #COVID19
News | Coronavirus (COVID-19)
COVID-19 Registry Tracks Cardiac Health of College Athletes

January 12, 2021 — The American Heart Association (AHA) and the American Medical Society for Sports Medicine (AMSSM) are ...

Home January 12, 2021
Home
While the FDA said the risk that SARS-CoV-2 virus mutations will only have a minor impact on testing accuracy is low, the agency singled out three tests are they had a higher concern. FDA warns PCR tests may be innaccurate with new UK virus varient.
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor
FDA Says New COVID Virus Mutation May Cause False Negatives

January 8, 2021 — The U.S. Food and Drug Administration (FDA) is alerting healthcare providers that it is monitoring the ...

Home January 08, 2021
Home
The most popular DAIC content in December 2020 included the Boston Scientific Lotus TAVR valve being taken off the market, CMS approving expanding coverage of LVADs for more Medicare patients and numerous COVID-19 related cardiology stories and videos.
Feature
Most Popular Cardiology Technology Content in December 2020

January 5, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home January 05, 2021
Home
The U.S. Government promised to have 20 million people vaccinated by Jan. 1, 2021 with just the Pfizer Vaccine. Even with two vaccines now approved, U.S. vaccinations for COVID stand at less than 4.5 million on Jan. 4, 2020. Getty Images The Pfizer and Moderna COVID vaccines were hailed as a major accomplishment in modern science and as the beginning of the end for COVID. This very well may be true, but it absolutely will not happen as fast as the government has led us to believe. #COVID19 #COVID #SARScov2
Blog | Coronavirus (COVID-19)
COVID Vaccines May Make the Future Brighter in 2021, if They Ever Arrive

There was much fanfare over the U.S. Food and Drug Administration (FDA) emergency use authorizations (EUAs) in December ...

Home January 04, 2021
Home
Who Can Get the COVID-19 Vaccine? Roberto Lang, M.D., director of noninvasive cardiac imaging, University of Chicago Medical Center and former American Society of Echocardiography (ASE) president, received his first dose of the COVID vaccine in December. In addition to front line hospital workers, nursing home staff and residents also qualified for the first round of vaccinations. Right, Shannon Yaw, a nurse at a hard-hit nursing home in Michigan, received her first dose just before Christmas.
News | Coronavirus (COVID-19) | Dave Fornell, Editor
Who Qualifies for the COVID Vaccine Under CDC Guidelines

The Centers for Disease Control and Prevention (CDC) Dec. 3, released an interim guidance document  to federal, state ...

Home January 04, 2021
Home
COVID-19 related topics by far out-paced all other topics in cardiology in 2020 on the DAIC website. Several stories topped the list related to the cardiovascular issues with hydroxychloroquine being used as a treatment for the virus. Top new device technologies in 2020 included European approval of the Abbott Tendyne transcatheter mitral valve, FDA approval of Medtronic's new Micra AV pill-sized pacemaker, and FDA clearance of the first drug-eluting stent with short-duration dual-antiplatelet therapy.
Feature | Dave Fornell, Editor
Top 25 Stories in Cardiology in 2020

Here are the top 25 best performing articles on the Diagnostic and Interventional Cardiology (DAIC) website from 2020 ...

Home December 28, 2020
Home
This year's top videos are dominated by COVID-19's impact on cardiology and many of the videos from a series produced this year on Tuft Medical Center's cardiology program. Top DAIC cardiology videos from 2020 #TuftsmedicalCenter #Tufts #COVID19
Feature | Dave Fornell, Editor
Top 25 Cardiology Videos on DAIC in 2020

Here are the top performing 25 videos on the DAIC website in 2020. The picks are based on Google Analytics of the DAIC ...

Home December 23, 2020
Home
Thrombus formation in the aortic arch in a 46-year-old COVID patients in the ICU. Three trials are underway to find which anticoagulant strategy is best to treat moderate and critically ill patients where COVID-causes venous thrombo-embolism (VTE) is a major cause of complications. Image courtesy of Margarita Revzin et al.
Feature | Coronavirus (COVID-19)
NIH Pauses Anticoagulant Trial For Critically Ill COVID-19 Patients

December 23, 2020 — Three clinical trial platforms working together to test the effects of full doses of anticoagulants ...

Home December 23, 2020
Home
The FDA December 18 issued an emergency use authorization (EUA) for a second COVID-19 vaccine from Moderna for use in individuals 18 years of age and older. #COVID19 #SARSCoV2 #Vaccine
News | Coronavirus (COVID-19)
FDA Approved Second COVID-19 Vaccine From Moderna

December 23, 2020 — The U.S. Food and Drug Administration December 18 issued an emergency use authorization (EUA) for a ...

Home December 23, 2020
Home
Coronavirus SARS-CoV-2 colorized scanning electron micrograph of a cell (pink) heavily infected with SARS-CoV-2 virus particles (teal and purple), isolated from a patient sample. Image courtesy of NIAID. MIS-C Multisystem inflammatory syndrome in children. #COVID19
News | Coronavirus (COVID-19)
NIH Begins Study of COVID Infection and Multisystem Inflammatory Syndrome in Children (MIS-C)

December 22, 2020 — An observational study has launched to evaluate the short- and long-term health outcomes of SARS-CoV ...

Home December 22, 2020
Home
Videos | EP Device Monitoring Systems
VIDEO: Rising Interest in Remote Monitoring of EP Devices in the COVID-19 Era

Robert Kowal, M.D., chief medical officer of the Medtronic cardiac rhythm and heart failure division, said there has ...

Home December 22, 2020
Home
COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office visit. Floyd Russak, M.D., of Russak Personalized Medicine, an internal medicine physician practicing in Greenwood Village, Colo., manages many cardiac patients who do not have ready access to a cardiologist
Feature | Wearables
Cardiac Monitoring in the Time of COVID-19: Next Generation Wearable ECG Technology Comes into Its Own

COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office ...

Home December 15, 2020
Home
The U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA) Dec, 12 for the COVID-19 vaccine submitted by Pfizer Inc. in partnership with BioNTech Manufacturing GmbH. It is the first mRNA vaccine to gain an FDA clearance and the first COVID vaccine to gain FDA clearance.  #COVID #COVID19 #SARSCoV2 #vaccine #COVIDVaccine
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor
FDA Clears First COVID-19 Vaccine Under an Emergency Use Authorization

December 14, 2020 — The U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA) for ...

Home December 14, 2020
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now